BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17505219)

  • 21. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
    Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer vaccines: what we know and what we don't yet know.
    von Mehren M
    Semin Oncol; 2005 Feb; 32(1):76-84. PubMed ID: 15726509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvants for cancer vaccines.
    Dubensky TW; Reed SG
    Semin Immunol; 2010 Jun; 22(3):155-61. PubMed ID: 20488726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer vaccine strategies get bigger and better.
    de Gruijl TD; Curiel DT
    Nat Med; 1999 Oct; 5(10):1124-5. PubMed ID: 10502808
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer vaccines: a promising cancer therapy against all odds.
    Silk AW; Finn OJ
    Future Oncol; 2007 Jun; 3(3):299-306. PubMed ID: 17547525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for vaccine therapy for pancreatic cancer.
    Gaudernack G
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):299-314. PubMed ID: 16549329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reengineering dendritic cell-based anti-cancer vaccines.
    Koski GK; Cohen PA; Roses RE; Xu S; Czerniecki BJ
    Immunol Rev; 2008 Apr; 222():256-76. PubMed ID: 18364007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination as a treatment for breast or ovarian cancer.
    Holmberg LA; Sandmaier B
    Expert Rev Vaccines; 2004 Jun; 3(3):269-77. PubMed ID: 15176943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic cancer vaccines.
    Morris LF; Ribas A
    Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in cancer vaccines: an overview.
    Itoh K; Yamada A; Mine T; Noguchi M
    Jpn J Clin Oncol; 2009 Feb; 39(2):73-80. PubMed ID: 19015149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic cancer vaccines: an emerging treatment option.
    King SE
    Clin J Oncol Nurs; 2004 Jun; 8(3):271-8. PubMed ID: 15208821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic approaches to breast cancer treatment.
    Sabel MS; Nehs MA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):1-31, v. PubMed ID: 15541997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulating the host response to autologous tumour vaccines.
    Ma J; Poehlein CH; Jensen SM; LaCelle MG; Moudgil TM; Rüttinger D; Haley D; Goldstein MJ; Smith JW; Curti B; Ross H; Walker E; Hu HM; Urba WJ; Fox BA
    Dev Biol (Basel); 2004; 116():93-107; discussion 133-43. PubMed ID: 15603186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
    Mocellin S; Nitti D
    Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development for a novel cancer vaccine].
    Tsunoda T
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2095-9. PubMed ID: 15628750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer vaccines: challenges and outlook in the field.
    Paul S; Acres B; Limacher JM; Bonnefoy JY
    IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.